Form 4: Bioxytran Director Milanova Reports Transactions in Company Stock
SEC Form 4 Filing
Director Radka Milanova reports acquisition and disposal of Bioxytran, Inc. common and preferred stock.
Summary
- Radka Milanova, a director of Bioxytran, Inc. (BIXT), filed a Form 4 detailing changes in beneficial ownership.
- On August 16, 2024, Milanova acquired 82,645 shares of common stock at $0.121 per share.
- On August 19, 2024, Milanova disposed of 182,645 shares of common stock at $0.131 per share.
- On August 19, 2024, Milanova acquired 36,529 shares of preferred stock at $0.655 per share.
- The transactions included a 5:1 exchange of common stock into convertible preferred stock with a 1:5 conversion ratio into common stock.
Sentiment
Score: 5
Explanation: The document is a routine disclosure of stock transactions by a company director, with no inherently positive or negative implications.
Industry Context
Form 4 filings are standard practice for company insiders to report transactions in their company's stock, providing transparency to investors.
Key Dates
| Date | Description |
|---|---|
| 08/16/2024 | Acquisition of 82,645 shares of common stock at $0.121 per share. |
| 08/19/2024 | Disposal of 182,645 shares of common stock at $0.131 per share and acquisition of 36,529 shares of preferred stock at $0.655 per share. |
| 08/20/2024 | Date of signature for the Form 4 filing. |
Keywords
Form 4, beneficial ownership, Bioxytran, BIXT, director, Radka Milanova, common stock, preferred stock, acquisition, disposal
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.